PERAN POTENSIAL BIOMARKER MOLEKULER DALAM MENILAI EFEKTIVITAS KLINIS INTERVENSI PROBIOTIK PADA PENYAKIT SALURAN PENCERNAAN

Gasela Zalianti Balqis; Jesika Cahya Ningrum; Giska Tri Putri; Maya Ganda Ratna

doi:10.59003/nhj.v5i8.1842

Authors

Gasela Zalianti Balqis Universitas Lampung
Jesika Cahya Ningrum Universitas Lampung
Giska Tri Putri Universitas Lampung
Maya Ganda Ratna Universitas Lampung

DOI:

https://doi.org/10.59003/nhj.v5i8.1842

Keywords:

Biomarker, Gastrointestinal, Inflammation, Probiotic, SCFA, Tight Junction

Abstract

Gastrointestinal diseases represent a significant global health burden and require complex management. Current assessments of probiotic efficacy often rely on subjective patient reports, which can be potentially biased. This review aims to explore the potential of molecular biomarkers to provide objective measures of therapeutic response. A narrative review was conducted through PubMed, Google Scholar, and Cochrane databases. The literature was screened using the PICO framework, focusing on gastrointestinal diseases, probiotic interventions, and molecular biomarker outcomes. Probiotic therapy effectively modulates the gut-brain axis and restores microbiota homeostasis. Specific biomarkers such as fecal calprotectin (inflammation), malondialdehyde (oxidative stress), and zonulin and occludin (barrier integrity) have been shown to be robust indicators for patient monitoring. Changes in these biomarkers significantly correlate with improvements in clinical symptoms, such as pain reduction and normalization of stool consistency. The integration of molecular biomarkers provides an objective, evidence-based framework for evaluating the efficacy of probiotic therapy, supporting the transition to precision medicine in gastroenterology.

Downloads

Download data is not yet available.

References

Simadibrata M, Prof F, Syam AF, Susilo A, Purnomo HD, Mariadi K, et al. Konsensus Nasional Penatalaksanaan Diare di Indonesia 2024. 2024;

Syamsul M, Adzim P, Mardan K. Peran Mikrobioma dalam Kesehatan Manusia : Perspektif Baru dalam Pengobatan. ALPHA J Sci Technol. 2025;1(1):23–7.

Simatupang DF, Mardiyah DU. Biomarker [Internet]. Tohar Media; 2024. 1 p. Available from: https://books.google.co.id/books?hl=en&lr=&id=wV00EQAAQBAJ&oi=fnd&pg=PP1&dq=.+Dalam+gastroenterologi,+biomarker+berfungsi+sebagai+alat+diagnosis,+prediktor+perkembangan+penyakit,+penentu+prognosis,+serta+indikator+keberhasilan+terapi.&ots=R2JbifcWWv&sig=Z

Wangko WS. Physiological aspects of short-chain fatty acids (SCFA). Med Scope J. 2020;2(1):26–35.

Gomi A, Yamaji K, Watanabe O, Yoshioka M, Miyazaki K, Iwama Y, et al. Bifidobacterium bifidum YIT 10347 fermented milk exerts beneficial effects on gastrointestinal discomfort and symptoms in healthy adults: A double-blind, randomized, placebo-controlled study. J Dairy Sci [Internet]. 2018;101(6):4830–41. Available from: http://dx.doi.org/10.3168/jds.2017-13803

Ohtsu T, Takagi A, Uemura N, Inoue K, Sekino H, Kawashima A, et al. The Ameliorating Effect of Lactobacillus gasseri OLL2716 on Functional Dyspepsia in Helicobacter pylori -Uninfected Individuals: A Randomized Controlled Study. Digestion. 2017;96(2):92–102.

Nakae H, Tsuda A, Matsuoka T, Mine T, Koga Y. Gastric microbiota in the functional dyspepsia patients treated with probiotic yogurt. BMJ Open Gastroenterol. 2016;3(1):1–8.

Guo P, Wang W, Xiang Q, Pan C, Qiu Y, Li T, et al. Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasis. Cell Host Microbe [Internet]. 2024;32(9):1502-1518.e9. Available from: https://doi.org/10.1016/j.chom.2024.07.028

Zhou J, Li M, Chen Q, Li X, Chen L, Dong Z, et al. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Nat Commun. 2022;13(1).

Li E, Wang J, Guo B, Zhang W. Effects of short-chain fatty acid-producing probiotic metabolites on symptom relief and intestinal barrier function in patients with irritable bowel syndrome: a double-blind, randomized controlled trial. Front Cell Infect Microbiol. 2025;15(June):1–11.

Kluijfhout S, Trieu T Van, Vandenplas Y. Efficacy of the probiotic probiotical confirmed in acute gastroenteritis. Pediatr Gastroenterol Hepatol Nutr. 2020;23(5):464–71.

Mitelmão FCR, Häckel K, Bergamaschi C de C, Gerenutti M, Silva MT, Balcão VM, et al. The effect of probiotics on functional constipation in adults: A randomized, double-blind controlled trial. Med (United States). 2022;101(43):E31185.

Naufal F, Farizy DF, Utama WT. Psikobiotik : Peran Mikrobiota Usus Dalam Kesehatan Jiwa Psychobiotics : Role of Gut Microbiota in Mental Health. Medula. 2020;10(3):545–51.

Ohtsu T, Haruma K, Ide Y, Takagi A. The effect of continuous intake of lactobacillus gasseri oll2716 on mild to moderate delayed gastric emptying: A randomized controlled study. Nutrients. 2021;13(6).

Takagi A, Yanagi H, Ozawa H, Uemura N, Nakajima S, Inoue K, et al. Effects of Lactobacillus gasseri OLL2716 on Helicobacter pylori -Associated Dyspepsia: A Multicenter Randomized Double-Blind Controlled Trial. Gastroenterol Res Pract. 2016;2016.

Patel BD, Kulkarni G, Chowdhuri S, Arya A, John KM, Doshi ASP, et al. Evaluation of Streptococcus faecalis, Clostridium butyricum, Bacillus mesentericus, Lactobacillus sporogenes, Saccharomyces Boulardi multistrain probiotic formulation in acute gastroenteritis: a real-world observational study (MAESTRO). BMC Nutr. 2025;11(1).

Kaur R, Gulati M, Singh SK. Role of synbiotics in polysaccharide assisted colon targeted microspheres of mesalamine for the treatment of ulcerative colitis. Int J Biol Macromol [Internet]. 2017;95:438–50. Available from: http://dx.doi.org/10.1016/j.ijbiomac.2016.11.066

Merenstein D, Fraser CM, Roberts RF, Liu T, Grant-beurmann S, Tan TP, et al. Bifidobacterium animalis subsp. lactis BB-12 Protects against Antibiotic-Induced Functional and Compositional Changes in Human Fecal Microbiome. 2021;

Marzet CB, Burgos F, Del Compare M, Gerold I, Tabacco O, Vinderola G. Approach to probiotics in pediatrics: the role of Lactobacillus rhamnosus GG. Arch Argent Pediatr. 2022;120(1):E1–7.

Singh A, Verma A, Ashraf S, Sheikh DS. Role of gut microbiota in the pathogenesis of metabolic syndrome : an updated comprehensive. :5851–61.

Peruhova M, Mihova A, Altankova I, Velikova T. Specific Immunoglobulin E and G to Common Food Antigens and Increased Serum Zonulin in IBS Patients: A Single-Center Bulgarian Study. Antibodies. 2022;11(2).

Martínez C, Rodinõ-Janeiro BK, Lobo B, Stanifer ML, Klaus B, Granzow M, et al. MiR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea. Gut. 2017;66(9):1597–610.

Guo J-G, Rao Y-F, Jiang J, Li X, Zhu S-M. MicroRNA-155-5p inhibition alleviates irritable bowel syndrome by increasing claudin-1 and ZO-1 expression. Ann Transl Med. 2023;11(2):34–34.

Awad K, Barmeyer C, Bojarski C, Nagel O, Lee IM, Schweiger MR, et al. Epithelial Barrier Dysfunction in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) via Downregulation of Claudin-1. Cells. 2023;

Schnadower D, O’Connell KJ, VanBuren JM, Vance C. Association Between Diarrhea Duration and Severity and Probiotic Efficacy in Children with Acute Gastroenteritis David. Physiol Behav [Internet]. 2017;176(10):139–48. Available from: file:///C:/Users/Carla%0ACarolina/Desktop/Artigos%0Apara%0Aacrescentar%0Ana%0Aqualificação/The%0Aimpact%0Aof%0Abirth%0Aweight%0Aon%0Acardiovascular%0Adisease%0Arisk%0Ain%0Afile:///C:/Users/Carla Carolina/Desktop/Artigos para acrescentar na qualificação/Th

Lai H, Li Y, He Y, Chen F, Mi B, Li J, et al. Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial. Gut Microbes [Internet]. 2023;15(1):1–15. Available from: https://doi.org/10.1080/19490976.2023.2197837

Dimidi E, Christodoulides S, Scott SM, Whelan K. Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation. Adv Nutr. 2017;8(3):484–94.